Level of HOXA5 hypermethylation in acute myeloid leukemia is associated with short-term outcome

Korean Journal of Laboratory Medicine

Volumn 30, Issue 5, 2010, Pages 469-473

  Kim, Shine Young ^a   Hwang, Sang Hyun ^c   Song, Eun Joo ^a   Shin, Ho Jin ^b   Jung, Joo Seop ^b   Lee, Eun Yup ^a,c  

^a Departments of Laboratory Medicine   (South Korea)

^b Department of Laboratory Internal Medicine ^*  (South Korea)

^c Pusan National University School of Medicine   (South Korea)

Author keywords

AML; HOXA5; Methylation

Indexed keywords

HOMEODOMAIN PROTEIN; HOXA5 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROMOTER REGION; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE;

ADULT; AGED; DNA METHYLATION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; ROC CURVE; SEQUENCE ANALYSIS, DNA; SURVIVAL RATE;

EID: 78049237820     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2010.30.5.469     Document Type: Article

References (15)

1. Cilio C, Cantile M, Faiella A, Bondnelli E. Homeobox genes in normal and malignant cells. J Cell Physiol 2001;188:161-9.
2. Abramovich C and Humphries RK. Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol 2005;12: 2104
3. Bird AP and Wolffe AP. Methylation-induced repression-belts, braces, and chromatin. Cell 1999;99:451-4.
4. Herman JG and Baylin SB. Gene silencing in cancer in association with promoter hyperrnethylation. N Engl J Med 2003;349:2042-54.
5. Strathdee G, Sim A, Parker A, Osder D, Brown R. Promoter hyperrnethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia 2006;20:1326-9.
6. Strathdee G, Holyoake TL, Sim A, Parker A, Osder DG, Melo JV, et al. Inactivation of HOXA genes by hyperrnethylation in myeloid and lymphoid malignancy is frequent and assodated with poor prognosis. Clin Cancer Res 2007;13:5048-55.
7. Drabkin HA, Parsy C, Ferguson K, Guilhot F, Lacotte L, Roy L, et al. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia 2002;16:186-95.
8. Golub TR, Slonim DK Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular dassification of cancer class discovery and dass prediction by gene expression monitoring. Science 1999;286:531-7.
9. Grimwade D, Walker H Oliver F, Wheatley K, Harrison Q Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998;92:2322-33.
10. Strathdee G, Sim A, Soutar R, Holyoake TL, Brown R. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia. Carcinogenesis 2007;28:299-309.
11. Vieille-Grosjean L Roullot V, Courtois G. Identification of homeoboxcontaining genes expressed in hematopoietic blast cells. Biochem Biophys Res Commun 1992;185:785-92.
12. Moretti P, Simmons P, Thomas P, Haylock D, Rathjen P, Vadas M, et aL Identification of homeobox genes expressed in human haemopoietic progenitor cells. Gene 1994;144:213-9.
13. Andreeff M, Ruvolo V, Gadgil S, Zeng C, Coombes K, Chen W, et al. HOX expression patterns identify a common signature for favorable AML. Leukemia 2008;22:2041-7.
14. Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, Rohatiner A, et al. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distind from those with translocation-mediated fusion events. Genes Chromosomes Cancer 2003;37:149-58.
15. Celetti A, Barba P, Cillo Q Rotoli B, Bondnelli E, Magii MC. Charaderistic patterns of HOX gene expression in different types of human leukemia. Int J Cancer 1993;53:237-44.